Amazon.com said patients with Medicare Part D prescription plans now have access to certain GLP-1 weight-loss medications through Amazon Pharmacy
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
Bank of America spends $250 million a year on GLP-1 drugs for its employees, CEO says
Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand
CVS Health Launches Eli Lilly GLP-1 Partnership, Lifts Outlook as Profit Increases
As Americans go direct with GLP-1 prescriptions, Walmart, Costco, Amazon will be big weight-loss winners
Midstream Operators Boost Payouts Into Q3 2026
Logistics giants are racing to keep up with healthcare boom as GLP-1s highlight need for cold storage
West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum
Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says
Novo Nordisk Sues GLP-1 Rival Eli Lilly For Misleading Advertising
Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
Novo Nordisk filed a lawsuit against rival Eli Lilly accusing it of using outdated studies to promote its GLP-1 drugs
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising